Flavonoid supplementation emerges as a promising treatment for non-alcoholic fatty liver disease.
“Non-alcoholic fatty liver disease, or NAFLD, causes fat accumulation in the liver, inflammation, and insulin resistance. It's the most common chronic liver condition among people in the United States, affecting roughly 90 percent of people with obesity, or about 38 percent of the overall population.”